Rockwell Medical, Inc. (RMTI) DCF Valuation

Rockwell Medical, Inc. (RMTI) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

Rockwell Medical, Inc. (RMTI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (RMTI) DCF Calculator! Equipped with real data from Rockwell Medical, Inc. and customizable assumptions, this tool empowers you to forecast, analyze, and evaluate (RMTI) just like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 61.3 62.2 61.9 72.8 83.6 90.6 98.2 106.4 115.3 124.9
Revenue Growth, % 0 1.46 -0.42767 17.57 14.84 8.36 8.36 8.36 8.36 8.36
EBITDA -31.5 -26.7 -27.8 -16.2 -4.7 -30.3 -32.8 -35.5 -38.5 -41.7
EBITDA, % -51.34 -42.96 -44.89 -22.2 -5.61 -33.4 -33.4 -33.4 -33.4 -33.4
Depreciation 2.7 2.3 2.5 2.6 1.4 3.1 3.4 3.7 4.0 4.3
Depreciation, % 4.33 3.68 4.06 3.56 1.73 3.47 3.47 3.47 3.47 3.47
EBIT -34.1 -29.0 -30.3 -18.8 -6.1 -33.4 -36.2 -39.2 -42.5 -46.1
EBIT, % -55.67 -46.64 -48.95 -25.76 -7.34 -36.87 -36.87 -36.87 -36.87 -36.87
Total Cash 26.0 58.7 22.4 21.5 10.9 39.1 42.3 45.9 49.7 53.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4,202.7 4.2 5.9 6.3 10.9
Account Receivables, % 6855.68 6.71 9.55 8.6 13.04
Inventories 3.6 3.9 4.1 5.8 5.9 6.1 6.6 7.2 7.8 8.5
Inventories, % 5.95 6.29 6.58 7.99 7.02 6.77 6.77 6.77 6.77 6.77
Accounts Payable 3.0 4.2 3.7 4.1 4.5 5.2 5.6 6.1 6.6 7.1
Accounts Payable, % 4.92 6.68 6.04 5.57 5.4 5.72 5.72 5.72 5.72 5.72
Capital Expenditure -1.3 -1.0 -.5 -.3 -.3 -1.0 -1.1 -1.2 -1.3 -1.4
Capital Expenditure, % -2.18 -1.68 -0.84287 -0.38594 -0.33966 -1.09 -1.09 -1.09 -1.09 -1.09
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -31.1 -30.0 -32.5 -20.7 -6.1 -32.8 -35.6 -38.5 -41.7 -45.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4,233.1 4,170.7 -32.8 -20.1 -9.2 -44.3 -35.4 -38.3 -41.5 -45.0
WACC, % 12.4 12.73 12.73 12.73 12.73 12.66 12.66 12.66 12.66 12.66
PV UFCF
SUM PV UFCF -144.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -46
Terminal Value -431
Present Terminal Value -237
Enterprise Value -382
Net Debt 4
Equity Value -386
Diluted Shares Outstanding, MM 23
Equity Value Per Share -16.56

What You Will Get

  • Pre-Filled Financial Model: Rockwell Medical's actual data facilitates accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Instant Calculations: Automatic updates provide immediate results as adjustments are made.
  • Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
  • Customizable and Reusable: Designed for versatility, enabling repeated use for comprehensive forecasts.

Key Features

  • 🔍 Real-Life RMTI Financials: Pre-filled historical and projected data for Rockwell Medical, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Rockwell Medical’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Rockwell Medical’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Rockwell Medical, Inc.'s (RMTI) preloaded data.
  • 2. Adjust Key Inputs: Modify essential parameters such as growth projections, WACC, and capital expenditures.
  • 3. Get Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
  • 4. Explore Different Scenarios: Analyze various forecasts to evaluate different valuation results.
  • 5. Present with Assurance: Deliver professional valuation insights to enhance your decision-making process.

Why Choose This Calculator for Rockwell Medical, Inc. (RMTI)?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for RMTI.
  • Customizable Inputs: Modify the highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Rockwell Medical’s intrinsic value and Net Present Value.
  • Preloaded Data: Access historical and projected data for a reliable analysis foundation.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on RMTI.

Who Should Use This Product?

  • Healthcare Professionals: Understand the latest treatment options and clinical data related to Rockwell Medical's therapies.
  • Researchers: Utilize advanced models to analyze the efficacy of Rockwell Medical's products in clinical studies.
  • Investors: Evaluate your investment strategies and assess the market potential of Rockwell Medical (RMTI).
  • Pharmaceutical Analysts: Enhance your analysis with a comprehensive overview of Rockwell Medical's financial health and market position.
  • Patients and Caregivers: Learn about the innovative solutions provided by Rockwell Medical and their impact on patient care.

What the Template Contains

  • Historical Data: Includes Rockwell Medical’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Rockwell Medical’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Rockwell Medical’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.